Background Cardiac injury associated with cytokine release frequently occurs in SARS-CoV-
2 mediated coronavirus disease (COVID19) and mortality is particularly high in these …

Aims Cardiac involvement is common in patients hospitalized with COVID-19 and correlates
with an adverse disease trajectory. While cardiac injury has been attributed to direct viral …

Rationale: While respiratory failure is a frequent and clinically significant outcome of
coronavirus disease 2019 (COVID-19), cardiac complications are a common feature in …

SARS-CoV-2 causes respiratory illness with a spectrum of systemic complications. However,
the mechanism for cardiac infection and cardiomyocyte injury in COVID-19 patients remains …

COVID-19 affects multiple organs. Clinical data from the Mount Sinai Health System shows
that substantial numbers of COVID-19 patients without prior heart disease develop cardiac …

Background SARS-CoV-2-mediated COVID-19 may cause sudden cardiac death (SCD).
Factors contributing to this increased risk of potentially fatal arrhythmias include thrombosis …

Heart injury has been reported in up to 20% of COVID-19 patients, yet the cause of
myocardial histopathology remains unknown. Here, using an established in vivo hamster …

Although COVID-19 causes cardiac dysfunction in up to 25% of patients, its pathogenesis
remains unclear. Exposure of human iPSC-derived heart cells to SARS-CoV-2 revealed …

Public health emergencies caused by Coronavirus-19 (COVID-19) continue to exist across
the globe. Studies have shown that infection with COVID-19 is more severe in people with …

Although coronavirus disease 2019 (COVID-19) causes cardiac dysfunction in up to 25% of
patients, its pathogenesis remains unclear. Exposure of human induced pluripotent stem cell …